Showing results (1131-1140 of 2,362) with videos related to

Sort By:
Pageof 237
World Journal of Urology|December 24, 2015
Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patientsAlessandro Conti, Matteo Santoni, Luciano Burattini, et al.
Oxidative Medicine and Cellular Longevity|April 8, 2020
Acute Effects of Triathlon Race on Oxidative Stress BiomarkersSimona Mrakic-Sposta, Maristella Gussoni, Alessandra Vezzoli, et al.
European Urology Oncology|June 18, 2019
Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate CancerArmando Stabile, Paolo Dell'Oglio, Matteo Soligo, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 25, 2023
One- and two-year clinical outcomes of treatment with resorbable magnesium scaffolds for coronary artery disease: the prospective, international, multicentre BIOSOLVE-IV registryAdrian Wlodarczak, Piero Montorsi, Jan Torzewski, et al.
International Journal of Impotence Research|July 3, 2020
Trends in reported male sexual dysfunction over the past decade: an evolving landscapeEdoardo Pozzi, Paolo Capogrosso, Luca Boeri, et al.
Andrology|July 10, 2020
The impact of metabolically healthy obesity in primary infertile men: Results from a cross-sectional studyWalter Cazzaniga, Luigi Candela, Luca Boeri, et al.
Iscience|November 17, 2022
Patient-specific forecasting of postradiotherapy prostate-specific antigen kinetics enables early prediction of biochemical relapseGuillermo Lorenzo, Nadia di Muzio, Chiara Lucrezia Deantoni, et al.
European Urology|April 21, 2020
Assessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral CentresRiccardo Campi, Daniele Amparore, Umberto Capitanio, et al.
Theranostics|March 17, 2025
Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer - a systematic review and meta-analysisGaia Ninatti, Pietro Scilipoti, Cristiano Pini, et al.
European Urology Oncology|November 9, 2023
Could a Risk-adapted Approach Support Shared Decision-making Regarding Eligibility for Adjuvant Pembrolizumab for Patients with Clear Cell Renal Cell Carcinoma at High Risk of Recurrence? A Multicentre Cohort StudyRiccardo Campi, Alessio Pecoraro, Eduard Roussel, et al.
Pageof 237